• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

CVS wants to play doctor with you

Claire Zillman
By
Claire Zillman
Claire Zillman
Editor, Leadership
Down Arrow Button Icon
Claire Zillman
By
Claire Zillman
Claire Zillman
Editor, Leadership
Down Arrow Button Icon
February 5, 2014, 10:30 PM ET
A CVS pharmacy in Manhattan

FORTUNE — On Wednesday, CVS announced that it will stop selling cigarettes and other tobacco products by October. The explanation: CVS is a health care provider, and cigarettes contradict its wellness mission.

That’s right. The store where you pick up an antibiotic and buy a box of Altoids now wants to test you for diabetes and identify that pesky rash.

The drugstore chain is already off to a good start. According to a December analyst report from J.P. Morgan, there are 800 CVS MinuteClinics in the U.S., and the company estimates that it will open at least 700 more by 2017.

“CVS Caremark is playing an expanded role in providing care through our pharmacists and nurse practitioners,” Larry Merlo, president and CEO of CVS (CVS), said in a statement.

MORE: CVS decision to stop selling cigarettes no big deal to Big Tobacco

Why? It’s fairly simple. There’s huge demand for convenient, timely primary health care.

Retail clinics started to pop up all over about a decade ago as standalone storefronts that offered a fast, easy, no-appointment-needed alternative to lengthy doctor’s office waits. Since then, retail clinics’ immediacy has only grown in value. As Obamacare prompts more Americans to sign up for insurance programs — 14 million new enrollees are expected this year – and those people gain access to affordable primary care, demand for primary care physicians is set to surge. That’s a problem since there’s already a huge shortage. The Association of American Medical Colleges projects that the shortage of doctors will grow to more than 91,500 by 2020. Primary care physicians, with their lower salaries and higher workloads, account for half of that figure.

The scarcity of primary care doctors could become even more acute as hospitals — which are under pressure from the Affordable Care Act’s tight limits on fees — abandon primary care in favor of what’s often a cheaper alternative: specialized services.

Hospitals are currently facing a fork in the road, says Mark Pauly, professor of health care management at the Wharton School of the University of Pennsylvania. “Some will become outpatient clinics with a few beds in the back, while others will focus much more on extraordinarily sick patients,” he says. Because specializing in just a few types of care allows hospitals to perfect their processes, that option often presents itself as the most economical.

MORE: What the drop in the market means for stocks (and the economy)

As some hospitals consider tiptoeing away from primary care, drug stores are embracing it head-on, not just because they want to fulfill the needs of customers-turned-patients, but because it makes good business sense. In-store clinics sync well with CVS’s large pharmacy benefit business, which brings in fees in exchange for managing insurers’ drug benefit programs, says Vishnu Lekaj, an analyst at Morningstar. Clinics, in driving foot traffic, also could increase CVS’s front-of-store retail sales, which were down in the third quarter of last year.

Despite the high demand for primary care, the profitability of the retail clinics isn’t certain. “In primary care, the key to making money is to keep overhead really low, and for multibillion companies, that’s really hard to do,” says health care consultant Jeff Goldsmith.

But for now, you can shop for a greeting card while you wait for those cholesterol level test results, and who doesn’t love a one-stop shop?

About the Author
Claire Zillman
By Claire ZillmanEditor, Leadership
LinkedIn iconTwitter icon

Claire Zillman is a senior editor at Fortune, overseeing leadership stories. 

See full bioRight Arrow Button Icon
0

Most Popular

placeholder alt text
Economy
Tariffs are taxes and they were used to finance the federal government until the 1913 income tax. A top economist breaks it down
By Kent JonesDecember 12, 2025
1 day ago
placeholder alt text
Success
Apple cofounder Ronald Wayne sold his 10% stake for $800 in 1976—today it’d be worth up to $400 billion
By Preston ForeDecember 12, 2025
1 day ago
placeholder alt text
Success
40% of Stanford undergrads receive disability accommodations—but it’s become a college-wide phenomenon as Gen Z try to succeed in the current climate
By Preston ForeDecember 12, 2025
1 day ago
placeholder alt text
Economy
The Fed just ‘Trump-proofed’ itself with a unanimous move to preempt a potential leadership shake-up
By Jason MaDecember 12, 2025
22 hours ago
placeholder alt text
Economy
For the first time since Trump’s tariff rollout, import tax revenue has fallen, threatening his lofty plans to slash the $38 trillion national debt
By Sasha RogelbergDecember 12, 2025
1 day ago
placeholder alt text
Success
Apple CEO Tim Cook out-earns the average American’s salary in just 7 hours—to put that into context, he could buy a new $439,000 home in just 2 days
By Emma BurleighDecember 12, 2025
1 day ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.